PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cancer Control and Population Sciences, National Cancer Institute, USA. Electronic address: croswellj@nih.gov.\', \'The Permanente Medical Group, Kaiser Permanente, Northern California, USA.\', \'University of North Carolina Lineberger Comprehensive Cancer Center and Eshelman School of Pharmacy, USA.\', \'Division of General Internal Medicine, Massachusetts General Hospital, USA.\', \'Department of Internal Medicine, University of Utah School of Medicine, USA.\', \'Kaiser Permanente Washington Health Research Institute, USA.\', \'Institute for Health Research, Kaiser Permanente Colorado, USA.\', \'Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, USA.\', \'Public Health Sciences Division, Fred Hutchinson Cancer Research Center, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0091-7435(21)00179-110.1016/j.ypmed.2021.106595
?:doi
?:hasPublicationType
?:journal
  • Preventive medicine
is ?:pmid of
?:pmid
?:pmid
  • 34217414
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 148
?:title
  • Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all